{"title": "Pharmaceutical companies tell Congress they expect coronavirus vaccine profits", "author": "Leandra Bernstein", "url": "https://katv.com/pharmaceutical-companies-tell-congress-they-expect-coronavirus-vaccine-profits", "hostname": "katv.com", "description": "The U. S. government has invested billions of taxpayer dollars into the development of coronavirus vaccines. On Tuesday, some of the top pharmaceutical companies told Congress that they intended to turn a profit on the most sought-after medical breakthrough. In a hearing of the House Energy and Commerce Committee, the leaders of five biopharmaceutical companies described their race to develop a safe and effective vaccine for COVID-19 on an accelerated timeline.", "sitename": "KATV", "date": "2020-07-21", "cleaned_text": "Pharmaceutical companies tell Congress they expect coronavirus vaccine profits by Leandra Bernstein This May 4, 2020 photo from the University of Maryland School of Medicine, the first patient enrolled in Pfizer's COVID-19 coronavirus vaccine clinical trial at the University of Maryland School of Medicine in Baltimore, receives an injection. (University of Maryland School of Medicine via AP) "}